M&T Bank
ALBO

M&T Bank’s Albireo Pharma Inc ALBO Stock Holding History

M&T Bank’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,524
Closed -$638K – 1766
2022
Q4 		$638K Buy
29,524
+4,562
+18% +$96.4K ﹤0.01% 1021
2022
Q3 		$484K Buy
24,962
+3,632
+17% +$75.1K ﹤0.01% 1099
2022
Q2 		$424K Buy
21,330
+1,030
+5% +$27.2K ﹤0.01% 1076
2022
Q1 		$606K Buy
20,300
+10,150
+100% +$297K ﹤0.01% 912
2021
Q4 		$236K Buy
10,150
+554
+6% +$14.7K ﹤0.01% 1373
2021
Q3 		$299K Hold
9,596
– – ﹤0.01% 1233
2021
Q2 		$338K Hold
9,596
– – ﹤0.01% 1212
2021
Q1 		$338K Sell
9,596
-273
-3% -$10.1K ﹤0.01% 1187
2020
Q4 		$370K Hold
9,869
– – ﹤0.01% 1221
2020
Q3 		$329K Hold
9,869
– – ﹤0.01% 1190
2020
Q2 		$261K Buy
+9,869
New +$233K ﹤0.01% 1263
2020
Q1 		– Sell
-7,951
Closed -$202K – 1722
2019
Q4 		$202K Buy
+7,951
New +$159K ﹤0.01% 1268
2019
Q2 		– Sell
-6,225
Closed -$201K – 1697
2019
Q1 		$201K Buy
+6,225
New +$168K ﹤0.01% 1418

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

M&T Bank's ALBO Position: Q1 2023 in Review

M&T Bank sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 29,524 shares — an estimated $638K sold.

M&T Bank first reported a position in ALBO in Q1 2019 and held it in 13 quarters. The position peaked at $638K in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • M&T Bank reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • M&T Bank sold 29,524 Albireo Pharma Inc shares in Q1 2023, an estimated $638K.
  • M&T Bank first reported a position in Albireo Pharma Inc in Q1 2019 and held it in 13 quarters.
  • M&T Bank's Albireo Pharma Inc position peaked at $638K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on M&T Bank's 13F filing for Q1 2023, filed 11 May 2023.